Opus Genetics, Inc. (IRD)
Latest IRD Insider Trades
About Opus Genetics, Inc. (IRD)
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.
- DURHAM, NC
- 28
- 2020
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 29,331 | $87K |
IRD Insider Transactions (Form 4)
3058 Form 4 filings on record, the earliest from Oct 24, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Benjamin R. Yerxa - Officer | Open-market sale | Common Stock | 7,429 |
Recent IRD Form 8-K Filings
5Recent IRD Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - |
IRD Insider Trading - FAQ
What is the latest insider trade for IRD?
Opus Genetics, Inc. (IRD) had 4 insider filings in the last 90 days, with the most recent on 2026-07-27. The full record for IRD runs to 58 Form 4 filings, the earliest from 2024-10-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying IRD stock?
No insider purchases of IRD were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling IRD stock?
4 insider sales of IRD were filed in the last 90 days, totaling $87K.
Where can I see IRD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks IRD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow IRD insider buys?
Create a free InsiderAlpha account and press Watch on this page to add IRD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Benjamin R. Yerxa view on EDGAR
- - Joseph K. Schachle view on EDGAR
- - George Magrath view on EDGAR
- - Robert E. Gagnon view on EDGAR
- - Foundation Fighting Blindness Retinal Degeneration Fund view on EDGAR
- - Benjamin R. Yerxa view on EDGAR
- - Joseph K. Schachle view on EDGAR
- - Rabourn Amy Zaremba view on EDGAR
- - George Magrath view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where IRD's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track IRD insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
